CVAUSA, the largest network of private cardiology groups in the U.S., plans to broadly adopt Flyrcado in line with its mission to deliver the highest quality cardiovascular care for patients. CVAUSA currently performs approximately 85,000 cardiac positron emission tomography (PET) procedures annually, highlighting the potential opportunity for Flyrcado as adoption grows. GE HealthCare remains committed to driving innovation and...Read more
End-to-end GLP-1 care done right: only FDA-approved medications and savings that set a new standard for weight management treatment SANTA MONICA, Calif. / Nov 17, 2025 / Business Wire / GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today announced two major initiatives to make FDA-approved GLP-1 medications more widely available. First, the launch of GoodRx for Weight Loss, a telemedicine subscription...Read more
BEIJING, Nov. 17, 2025 /PRNewswire/ -- So-Young International Inc. (Nasdaq: SY) ("So-Young" or the "Company"), the leading aesthetic treatment platform in China connecting consumers with online services and offline treatments, today announced its unaudited financial results for the third quarter ended September 30, 2025. Third Quarter 2025 Financial Highlights Total revenues were RMB386.7 million (US$54.3 million[1]), compared...Read more
MINNEAPOLIS, Nov. 17, 2025 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq:ONMD) (“OneMedNet,” the “Company,” “we,” “us” or “our”), a leader in AI-powered Real-World Data (RWD), announced its financial results for the third quarter ended September 30, 2025 and operational highlights. Third Quarter Financial Highlights Bookings: $1.1M in third quarter 2025 bookings, an 815% increase compared to third quarter of 2024. Private...Read more
CHICAGO / Nov 16, 2025 / Business Wire / GE HealthCare (Nasdaq: GEHC) management will present at the following upcoming investor conference. Jefferies Global Healthcare Conference in London, England – Tuesday, November 18, 2025 at 9:30 am GMT/4:30 am ET/3:30 am CT GE HealthCare’s CFO, Jay Saccaro, will discuss a variety of topics related to business strategy and growth opportunities. He will also comment on questions that have...Read more
LONG BEACH, Calif. / Nov 14, 2025 / Business Wire / Molina Healthcare, Inc. (NYSE: MOH) (“Molina”) announced today that the Florida Agency for Health Care Administration (AHCA) has issued a Notice of Agency Decision that it intends to award Molina Healthcare of Florida a contract to provide Statewide Medicaid Managed Care (SMMC) Program and Children’s Health Insurance Program (CHIP) services to enrollees of the Title XIX and Title XXI...Read more
Company to offer the first clinically validated dietary management of sarcopenia, now available for GLP-1 muscle loss, positioning Wellgistics to help 6,500+ independent pharmacy network ('Pharmacy Network') and telehealth partners mitigate patient muscle loss in the GLP-1 drug market, estimated to grow to $150 billion by 2030 Company to offer first SARS-CoV-2 related natural antiviral combo for Long COVID with addition of 3CL...Read more
Nation's Largest HSA Custodian Leverages Parloa’s Advanced AI Technology to Deliver Personalized, Conversational Support for Millions of Members DRAPER, Utah, Nov. 13, 2025 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (Nasdaq: HQY), the nation's largest Health Savings Account (HSA) and consumer-directed benefits administrator, today announced a new development in building upon its technology investments to transform member experience. The...Read more
NEW YORK, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, today announced that Mark Livingston, Progyny’s Chief Financial Officer, will participate in a fireside chat at the Jefferies Global Healthcare Conference on Tuesday, November 18, 2025, at 3:00 p.m. GMT / 10:00 a.m. ET. A live audiocast and replay will be available from the Events and Presentations...Read more
CERRITOS, Calif., Nov. 13, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI” or the “Company”), one of the largest value-based community oncology groups in the United States, today reported financial results for its three months ended September 30, 2025 and updated its full year 2025 guidance. Recent Operational Highlights Fee-for-service revenue growth of 13% over Q3 2024, driven by continued organic growth...Read more
Partnership deployed touchless prior authorization system in eight weeks, achieving 95% reduction in authorization workload CERRITOS, Calif. and NEW YORK, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Ascertain, a healthcare technology company pioneering agentic AI to automate administrative workflows, and The Oncology Institute, Inc. (NASDAQ: TOI), a leading value-based oncology care provider, today announced a co-development partnership to...Read more
Third quarter total revenue of $22.1 million, up 26% year-over-year Positive cash flows, with Adjusted EBITDA(1) of $1.5 million, up 98% year-over-year, and our 27th consecutive quarter of positive Adjusted EBITDA Investor webinar scheduled for Thursday, November 13, 2025 at 10:00 AM ET / 7:00 AM PT TORONTO / Nov 13, 2025 / Business Wire / NeuPath Health Inc. (TSXV:NPTH), (“NeuPath” or the “Company”), owner and operator of a network...Read more
P3 Reports Continued Operational Progress and Expansion of Care Enablement Model in a Transitional Year $120 to $170 Million EBITDA Expansion Opportunity Strengthens Path to Meaningful Profitability Management to Host Conference Call and Webcast November 14, 2025 at 8:00 AM ET HENDERSON, Nev. / Nov 13, 2025 / Business Wire / P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led...Read more
Dallas, Texas, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) ("Mangoceuticals" or the "Company"), a company focused on developing, marketing, and selling a variety of health and wellness products via a secure telemedicine platform under the brands MangoRx and PeachesRx, and a pioneer in innovative wellness solutions, is excited to announce that it has launched MangoRx Direct and PeachesRx Direct, two integrated...Read more
Third Quarter Revenue Increased 2.5% Period over Period with 42.3% EBITDA Growth Revenue for the First Nine Months Increased 5.6% Year Over Year Signs Existing Health System to 10 Year Extension and an Upgrade to their Gamma Knife System Conference Call Scheduled for 1:00 PM ET Today SAN FRANCISCO, Nov. 13, 2025 (GLOBE NEWSWIRE) -- American Shared Hospital Services (NYSE American: AMS) (the "Company"), a leading provider of...Read more
BRENTWOOD, Tenn. / Nov 12, 2025 / Business Wire / Ardent Health, Inc. (NYSE: ARDT) ("Ardent Health" or the "Company"), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced results for the quarter ended September 30, 2025. Third Quarter 2025 Operating and Financial Summary All comparisons are versus the same prior year period. See the footnotes to the Operating Statistics table of this...Read more
MCLEAN, Va. / Nov 12, 2025 / Business Wire / Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today announced the commencement of an underwritten public offering (the “Offering”) of 1,500,000 shares of its Class A common stock, par value $0.0001 per share (the “Class A common stock”), by certain affiliates of...Read more
Continued Turnaround Driven by Cost Discipline and Operational Efficiency; Positioned for Strong 2026 Growth TAMPA, Fla., Nov. 12, 2025 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX: MRAI), a leader in innovative healthcare technology and Third-Party Administration (TPA) services, announced third quarter 2025 results that mark another quarter of significant operational and financial improvement,...Read more
Technical insights session to highlight human-in-the-loop AI agent workflows in drug development GAITHERSBURG, Md., Nov. 12, 2025 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development company using artificial intelligence (“AI”) and machine learning to enable the successful development of pharmaceuticals and biologics, today announced that it...Read more
Consolidates messaging around Einstein Rx AI, Wellgistics Hub (formerly DelivMeds) and HubRx AI integration with pharmacies (in-house pharmacy and 6,500+ independent pharmacy network), physicians and manufacturers Integration of technology and physical infrastructure positions Wellgistics with the "Pharmacy IT Railroad" to execute on PharmacyChain™ smart contracts for optimized healthcare delivery in the $634 billion United...Read more
BOSTON, Nov. 11, 2025 /PRNewswire/ -- Complete Genomics, a leading innovator in genomic sequencing, today announced a collaboration with SOPHiA GENETICS (NASDAQ: SOPH), a global leader in AI-driven precision medicine, to launch and co-market MSK-ACCESS® and MSK-IMPACT® powered with SOPHiA DDM™ on Complete Genomics' DNBSEQ-T1+ sequencing platform. The companies aim to broaden access to precision oncology testing by offering the...Read more
BOSTON and SAN DIEGO, Nov. 11, 2025 /CNW/ -- SOPHiA GENETICS (NASDAQ: SOPH), a global leader in AI-driven precision medicine, and Element Biosciences, Inc., a biology company transforming the pace and accessibility of scientific discovery, today announced at the Association for Molecular Pathology (AMP) Annual Meeting a partnership that unites sequencing and AI analytics to streamline genomic workflows and accelerate the research...Read more
The 50-bed inpatient rehabilitation hospital is a joint venture between Encompass Health and BSA Health System. BIRMINGHAM, Ala. and AMARILLO, Texas, Nov. 10, 2025 /PRNewswire/ -- Today, Encompass Health, the nation's largest owner and operator of inpatient rehabilitation hospitals, along with BSA Health System, the largest health care employer in the Texas Panhandle region, announced the opening of Rehabilitation Hospital of...Read more
MIAMI / Nov 10, 2025 / Business Wire / Oscar Health, Inc. (“Oscar”) (NYSE: OSCR), a leading healthcare technology company, today is introducing affordable, tech-powered health plans for individuals, families, and businesses across Southern Florida on the individual marketplace for 2026 Open Enrollment. Local residents can now experience the Oscar difference – healthcare that’s simple, personal, and easy to use at every step. Oscar – the...Read more
BRENTWOOD, Tenn., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners” or the “Company”), a leading short-stay surgical facility owner and operator, today announced results for the third quarter ended September 30, 2025. Third Quarter 2025 Financial Highlights (All comparisons are year-over-year unless otherwise noted) Revenue increased 6.6% for the third quarter Same-facility revenues...Read more
DALLAS / Nov 10, 2025 / Business Wire / Sonida Senior Living, Inc. (the “Company,” “Sonida,” “we,” “our,” or “us”) (NYSE: SNDA), a leading owner, operator and investor of senior housing communities, today announced its results for the third quarter ended September 30, 2025. “In the third quarter, total portfolio community NOI grew approximately 21%, driven by solid rent growth and strong results in the acquisition portfolio,” said Brandon...Read more
Program will advance equitable, accessible mental health care for women by integrating specialized clinical expertise with Talkspace’s virtual care platform NEW YORK / Nov 10, 2025 / Business Wire / Talkspace, a leading online behavioral health company, today announced the launch of Chapters by Talkspace, a new clinical program designed to address the unique mental health and wellness needs of women throughout their lifespan. Chapters...Read more
SALT LAKE CITY, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (“Health Catalyst,” Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter ended September 30, 2025. “For the third quarter of 2025, I am pleased by our financial results, including total revenue of $76.3 million and Adjusted EBITDA of $12.0 million, with these...Read more
Company Achieves Record Volumes Across All Major Business Lines Management to Host Conference Call and Webcast Today at 5:00 PM Eastern Time NEW YORK / Nov 10, 2025 / Business Wire / DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health and medical transportation services, today announced financial and operating results for the quarter ended September 30, 2025. Third Quarter 2025...Read more
MINNEAPOLIS, Nov. 10, 2025 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet” or the “Company”), a leader in AI-empowered Real-World Data (RWD), today announced that it will demonstrate its next-generation iRWD™ platform at ISPOR Europe. Built on the Palantir Technologies Foundry ecosystem, the platform enables life sciences, diagnostics, and medical device organizations to securely generate and analyze...Read more
MURFREESBORO, Tenn. / Nov 07, 2025 / Business Wire / National HealthCare Corporation (NYSE American: NHC), the nation's oldest publicly traded senior health care company, announced today net operating revenues for the quarter ended September 30, 2025 totaled $382,661,000 compared to $340,198,000 for the quarter ended September 30, 2024, an increase of 12.5%. The increase in net operating revenues for the third quarter of 2025 compared to...Read more
Q3 2025 Revenues of $246.0 million grew 6.7% compared to Q3 2024 Net Loss of $69.8 million Adjusted EBITDA of $155.1 million increased 9.5% compared to Q3 2024 Adjusted EBITDA Margin of 63.1% versus 61.5% in Q3 2024) Claritev raises full-year 2025 revenue and Adjusted EBITDA guidance MCLEAN, Va. / Nov 07, 2025 / Business Wire / Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV), a technology, data and insights company...Read more
MIAMI BEACH, Fla., Nov. 07, 2025 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (NASDAQ:AIRS)(“AirSculpt” or the “Company”), a national provider of premium body contouring procedures, today announced results for the third quarter ended September 30, 2025. Yogi Jashnani, Chief Executive Officer, stated: “During the quarter, we made strong progress on our key initiatives that focused on new growth opportunities, margin improvement, and...Read more
Reported sales increased 0.7%; organic sales increased 2.7% Expects full year organic sales growth to be at the high end of +2.0% to +3.0% range Increases full year adjusted earnings per share outlook to $5.98 to $6.08 Announces 4-year 'Transform for the Future' initiative ST. PAUL, Minn., Nov. 6, 2025 /PRNewswire/ -- Solventum (NYSE: SOLV) today reported financial results for the third quarter ended September 30, 2025. Third...Read more
Total revenues of $168.5 million, up 23% year-over-year Operating cash flow of $93.9 million, up 37% year-over-year Free cash flow of $91.6 million, up 37% year-over-year SAN FRANCISCO / Nov 06, 2025 / Business Wire / Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2026 second quarter ended September 30, 2025. “Our platform continues to grow with new AI...Read more
Powered by GeneDx Infinity™ with unparalleled scale and diversity, GeneDx fuels breakthrough scientific research and delivers the most precise rare disease diagnosis for patients and families GAITHERSBURG, Md. / Nov 06, 2025 / Business Wire / GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced it will unveil research findings during four key sessions at the 2025 National...Read more
NEW YORK / Nov 06, 2025 / Business Wire / Oscar Health, Inc. (“Oscar” or the “Company”) (NYSE: OSCR) announced today its financial results for the third quarter ended September 30, 2025, and reaffirmed its full year 2025 outlook, across all metrics, as provided in its preliminary financial results press release dated July 22, 2025. “The individual market is the only source of affordable health coverage for 22 million people who power our...Read more
Very Strong Third Quarter and Year-to-Date Performance Across the Business Net Income +94.1% and Adjusted EBITDA +61.6% compared to 3Q’24 Implemented Providers +13.1% and Practice Collections +27.1% compared to 3Q’24 FY’25 Guidance Raised Above High End for All Key Operating and Financial Metrics ARLINGTON, Va., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced financial results for the...Read more
NASHVILLE, Tenn., Nov. 6, 2025 /PRNewswire/ -- Brookdale Senior Living Inc. (NYSE: BKD) ("Brookdale" or the "Company") announced results for the quarter ended September 30, 2025. HIGHLIGHTS Third quarter consolidated weighted average occupancy of 81.8% increased 290 basis points year-over-year, and third quarter same community weighted average occupancy of 82.3% increased 260 basis points year-over-year. Same community...Read more
SCOTTSDALE, Ariz., Nov. 06, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation’s largest providers of outpatient mental healthcare, today announced financial results for the third quarter ended September 30, 2025. (All results compared to prior-year comparative period, unless otherwise noted)Q3 2025 Highlights and FY 2025 Outlook Revenue of $363.8 million increased 16% compared to revenue of...Read more
Reports Revenue of $313.3 Million, Reflecting 9.3% Growth Raises Full Year Guidance to Reflect Continued Strength in Member Engagement Selling Season Yields Over 80 New Clients, 900,000 New Lives, and Near 100% Retention of Existing Base Record $156.0 Million in Operating Cash Flow Generated over the First Nine Months of 2025 Board Authorizes Up to $200 Million in Share Repurchase Program NEW YORK, Nov. 06, 2025 (GLOBE NEWSWIRE)...Read more
PLEASANTON, Calif., Nov. 6, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today reported financial results for the third quarter ended September 30, 2025. Recent Updates Revenue was $149.0 million for the third quarter, compared to $172.9 million in the second quarter, which included $27.3 million related to one-time license and royalty revenue. Third quarter revenue...Read more
Third Quarter Revenue was $621.9 million, a 22.2% increase over the prior year period Third Quarter Net income was $14.1 million compared to Net loss of $42.8 million for the prior year period Adjusted EBITDA for Q3 2025 was $80.1 million, a 67.5% increase over the prior year period Increased Full Year 2025 Revenue guidance to greater than $2.375 billion, updated from greater than $2.3 billion Increased Full Year 2025 Adjusted...Read more
Updates Full Year 2025 Financial Guidance RADNOR, Pa., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today reported its financial results for the third quarter of fiscal year 2025. Third Quarter Highlights: Revenue was $104.6 million, compared to $94.8 million in the third quarter of 2024, representing growth of 10%. Software revenue was $43.8 million,...Read more
NEW YORK / Nov 06, 2025 / Business Wire / Schrödinger, Inc. (Nasdaq: SDGR) today announced that management will participate in a fireside chat at the Jefferies London Healthcare Conference. The live presentation will take place on Wednesday, November 19, at 4:00 p.m. GMT (11:00 a.m. ET). The live webcast can be accessed in the “Investors” section of Schrödinger’s website and will be archived for approximately 90 days following the...Read more
Company to Host Conference Call on Thursday, November 6, 2025, at 2:30 p.m. PT/5:30 p.m. ET Reports total revenue of $956.0 million, up 100% year-over-year, and at the higher end of guidance Reports adjusted EBITDA of $68.5 million, at the higher end of guidance Closes Prospect Health acquisition where standalone third quarter performance exceeded expectations Continuing to control medical costs well; reiterating full-year trend...Read more
WELL achieved record quarterly revenues of $364.6 million in Q3-2025, an increase of 56% compared to Q3-2024 driven by organic growth and acquisitions. Excluding the impact of Circle Medical’s deferred revenue adjustments or “CM Deferrals”(1), revenue would have been $347.0 million in Q3-2025, representing 48% YoY growth. WELL achieved record Adjusted EBITDA(1) of $59.9 million in Q3-2025, an increase of 296% compared to $15.1 million in...Read more
Quarterly revenue of $634 million and adjusted EBITDA of $58 million; GAAP income of $0.76/share and adjusted EPS of $0.39 DALLAS, Nov. 06, 2025 (GLOBE NEWSWIRE) -- AMN Healthcare Services, Inc. (NYSE: AMN), the leader and innovator in total talent solutions for healthcare organizations across the United States, today announced its third quarter 2025 financial results. Financial highlights are as follows: Dollars in millions,...Read more
Annual Recurring Revenue (ARR)⁽¹⁾ up 75% YoY to $93.7 million Total Revenue up 94% YoY to $32.0 million Adjusted EBITDA⁽¹⁾ up 58% YoY to $7.2 million TORONTO, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Vitalhub Corp. (TSX:VHI) (OTCQX:VHIBF) (the “Company” or “VitalHub”) announced today it has filed its Interim Condensed Consolidated Financial Statements and Management's Discussion and Analysis report for the three and nine months ended...Read more
WASHINGTON, Nov. 6, 2025 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company focused on achieving better health outcomes for people with complex conditions, and American Oncology Network (AON), one of the nation's fastest-growing community oncology networks, today announced a new model enabling high-quality, more affordable, and connected cancer care — all without relying on prior authorization. The national partnership...Read more
Q3 2025 financial results ahead of expectations. Announces more than $500 million in newly-contracted annualized revenue to launch in 2026. Expands leadership team to support accelerating growth. WASHINGTON, Nov. 6, 2025 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH) ("Evolent" or the "Company"), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make health...Read more
MOBILE, Ala. / Nov 06, 2025 / Business Wire / TruBridge, Inc. (NASDAQ: TBRG), a leading provider of revenue cycle management and healthcare technology solutions for rural and community healthcare organizations, today announced financial results for the third quarter and nine months ended September 30, 2025. Third Quarter 2025 Highlights All comparisons are to the quarter ended September 30, 2024, unless otherwise noted Total bookings...Read more
HEALWELL achieved quarterly revenue from continuing operations of $30.4 million in Q3-2025, an increase of 354% compared to revenue of $6.7 million generated in Q3-2024. Revenue growth in the quarter was largely driven by the Orion Health acquisition. During Q3-2025, HEALWELL reported positive Adjusted EBITDA of $0.7 million, compared to an Adjusted EBITDA loss of $2.8 million in Q3-2024. This marks the Company's second consecutive...Read more
Q3 revenue of $26.1 million, increased 22% year-over-year Q3 gross profit increased 30% year-over-year to $17.5 million Increases full year 2025 guidance to a revenue range between $105 million and $109 million and adjusted EBITDA range between $16 million and $19 million Introduces 2026 guidance with a revenue range between $118 million and $124 million and adjusted EBITDA range between $19 million and $22 million Paid off an...Read more
Third Quarter Revenue Delivered at High End of Guidance FRAMINGHAM, Mass., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare” or the “Company”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced financial results for the quarter ended September 30, 2025. Third Quarter 2025 Financial Highlights: Revenue was $60.0 million, a decrease of 4% from $62.7...Read more
TORONTO, Nov. 6, 2025 /CNW/ - Medical Facilities Corporation ("Medical Facilities," "MFC," or the "Corporation") (TSX: DR), reported its financial results today for the three-month and nine-month periods ended September 30, 2025. All amounts are expressed in U.S. dollars unless indicated otherwise. Q3 2025 Highlights (For continuing operations1, excluding government stimulus income, and non-controllable, non-cash corporate level charges...Read more
Raises Revenue Guidance, Completes Medsphere Acquisition and Accelerates AI Initiative SOMERSET, N.J., Nov. 06, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD, CCLDO), a leader in healthcare technology and generative AI solutions, today announced strong financial results for the quarter ended September 30, 2025, and is increasing its full-year 2025 revenue guidance to $117 – $119 million, up from the initial range of...Read more
Grew Revenue 6%, Compared to Third Quarter 2024 - Board Authorizes an Additional $12 Million for Share Repurchases SCOTTSDALE, Ariz., Nov. 06, 2025 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), a national operator, manager, and franchisor of chiropractic clinics, posted operating highlights and limited financial information for the third quarter ended September 30, 2025. The following figures represent continuing...Read more
HALIFAX, Nova Scotia, Nov. 06, 2025 (GLOBE NEWSWIRE) -- NOVA LEAP HEALTH CORP. (TSXV: NLH) (“Nova Leap” or “the Company”), a growing home health care organization, is pleased to announce the release of record financial results for the quarter ended September 30, 2025. All amounts are in United States dollars unless otherwise specified. During the quarter, Nova Leap achieved the following record results: Record consolidated quarterly...Read more
New capability to provide tailored and coordinated care informed by behavioral insights SAN FRANCISCO, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual-first, between-visit health care provider, today announced the planned launch of its prescribing capability. After reporting 53% year-over-year member growth as of the end of Q3, the company is also expanding its offerings. A new option of prescribing and...Read more
Revenue of $68 million, up 49%; 53% Member Growth Significant Reduction in Net Loss and First Quarter of Positive Adjusted EBITDA Announces New GLP-1 Prescribing Offering SAN FRANCISCO, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Omada Health, Inc. (Nasdaq: OMDA), the virtual between-visit healthcare provider, today reported financial results for the third quarter ended September 30, 2025. 2025 Third Quarter Highlights Total members of...Read more
Reports 3Q25 earnings per share (EPS) of $1.62 on a GAAP basis, Adjusted EPS of $3.24; reports YTD EPS of $16.43 on a GAAP basis, $21.10 on an Adjusted basis 3Q25 Insurance segment benefit ratio of 91.1 percent, in line with the company's previously disclosed expectation of 'just above 91 percent' Updates FY 2025 GAAP EPS guidance to 'approximately $12.26' from the previous estimate of 'approximately $13.77'; affirms Adjusted FY 2025...Read more
Third Quarter Revenue of $851.6 Million Increased 4.4% Year-Over-Year Lowering Full-Year Outlook Acadia Taking Decisive Actions to Optimize Portfolio in Order to Reduce Capital Expenditures and Increase Free Cash Flow Generation Referral Initiatives Drive Accelerating Admissions Growth Todd Young joined as CFO on October 27; Announces departure of COO Dr. Nasser Khan FRANKLIN, Tenn. / Nov 05, 2025 / Business Wire / Acadia...Read more
Third Quarter Total Revenue of $54.3 Million, Software Revenue of $40.9 Million Updates 2025 Financial Guidance NEW YORK / Nov 05, 2025 / Business Wire / Schrödinger, Inc. (Nasdaq: SDGR) today announced financial results for the quarter ended September 30, 2025. "Schrödinger delivered a solid third quarter with software revenue growth of 28%, reflecting the industry’s increasing demand for our leading computational platform,” said...Read more
HOUSTON / Nov 05, 2025 / Business Wire / U.S. Physical Therapy, Inc. (“USPH” or the “Company”) (NYSE, NYSE Texas: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, today reported results for the three and nine months ended September 30, 2025. FINANCIAL HIGHLIGHTS Adjusted EBITDA (1), a non-Generally Accepted Accounting Principles (“GAAP”) measure, was $23.9 million...Read more
Conference Call and Webcast scheduled for tomorrow, November 6, 2025 at 10:00 am MT EAGLE, Idaho, Nov. 05, 2025 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, today announced its operating results, reporting GAAP diluted earnings per share of $0.17 for the third quarter of 2025. Pennant also reported adjusted...Read more
Company to host a conference call tomorrow, November 6, 2025, at 9:00 a.m. EST DALLAS / Nov 05, 2025 / Business Wire / Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice care provider, today reported its results of operations for the third quarter ended Sept. 30, 2025. “Our third quarter results reflect strong execution on our core strategic priorities, with year-over-year growth in revenue, census and Adjusted EBITDA,”...Read more
Continued progress against strategic priorities Repurchased approximately one million shares of Class A common stock Reiterates 2025 financial guidance Third Quarter 2025 Financial Highlights Revenue of $48.0 million Gross profit margin of 71.8% Net income of $9.2 million and diluted earnings per share attributable to biote Corp. stockholders of $0.22, compared to net income of $12.7 million and diluted earnings per share...Read more
New applications include Veeva LIMS Basics and PromoMats Basics to drive speed and growth PLEASANTON, Calif., Nov. 4, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that more than 100 biotechs have selected Veeva Basics to advance operations across clinical, regulatory, and quality. A growing number of biotechs in the U.S. and Europe are establishing a foundation for growth with a simple and standard industry-leading...Read more
Strong organic revenue growth1 of 10% driven by all operating segments Positive U.S. same market treatment growth of 0.1 % in line with expectations Accelerated operating income2 growth of 28% at constant currency, leading to a step-change in margin expansion to 11.7% Reported operating income grew by 3%, reported net income3 by 29% Net leverage ratio further improved to 2.6x, in parallel to share buyback and Value-Based Care...Read more
First-quarter total net revenue of $240.0 million (total net revenue excluding Contigo Health* of $234.7 million) First-quarter GAAP net income from continuing operations of $15.3 million, or $0.21 per fully diluted share First-quarter adjusted earnings per share of $0.32, excluding Contigo Health* CHARLOTTE, N.C. / Nov 04, 2025 / Business Wire / Premier, Inc. (NASDAQ: PINC), a leading technology-driven healthcare improvement...Read more
Business Highlights: Generates third quarter year-to-date positive Adjusted EBITDA profitability, on a wide network, while growing membership by 35% and revenue by 39% year-over-year, despite a greater proportion of new members relative to returning member base High coverage of Clover Assistant, including within new cohorts, will result in improved total cost of care Strong retention, above-market growth, and profitable returning...Read more
EAGLE, Idaho, Nov. 04, 2025 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice, home care and senior living companies, announces two significant acquisitions that strengthen its presences in key markets. Effective November 1, 2025, Pennant acquired the operations and real property of a 55-bed assisted living community in Lewiston, Idaho. This community,...Read more
DENVER, Nov. 04, 2025 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge” or the “Company”) (Nasdaq: INNV), an industry leader in providing comprehensive healthcare programs to frail, predominantly dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE), today announced financial results for its fiscal first quarter ended September 30, 2025. “We’re off to a strong start in fiscal 2026,” said Patrick...Read more
Company Maintains Full Year 2025 Revenue and Adjusted EBITDA Expectations; Raises Pharma Manufacturer Solutions Revenue Outlook to Approximately 35% Year-Over-Year Growth for 2025 SANTA MONICA, Calif. / Nov 04, 2025 / Business Wire / GoodRx Holdings, Inc. (Nasdaq: GDRX) ("we," "us," "our," “GoodRx,” or the “Company”), the leading platform for medication savings in the U.S., has released its financial results for the third quarter of...Read more
BOSTON and ROLLE, Switzerland, Nov. 4, 2025 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a global leader in AI-driven precision medicine, today reported financial results for the third quarter ended September 30, 2025. Third Quarter 2025 Financial Results Revenue was $19.5 million, up 23% year-over-year Gross margin was 66.3% on a reported basis and 73.1% on an adjusted basis, compared to 67.2% reported and 73.1%...Read more
Continued Progress on Transformation Initiatives Including the Execution of $30 million in 2026 Operating Cost Reductions WESTERVILLE, Ohio / Nov 04, 2025 / Business Wire / agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, today announced results for the third quarter ended September 30, 2025 and provided a full-year 2025 outlook. “In the third quarter we made...Read more
Expansion of Current Customer Relationship Will Utilize Combination of On-Site Mobile Clinicians and Telehealth Services to Deliver Comprehensive Care NEW YORK / Nov 04, 2025 / Business Wire / DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health and medical transportation services, today announced plans to launch Longitudinal Care Services in partnership with a California-based...Read more
BOSTON , Nov. 04, 2025 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, today announced financial results for the third quarter ended September 30. The company’s third quarter earnings report may be viewed at investors.amwell.com. Amwell will host a conference call to discuss its financial results today at 5 p.m. ET. The call can be accessed...Read more
Vancouver, British Columbia, Canada, November 4, 2025 – TheNewswire - PanGenomic Health Inc. (“PanGenomic Health” or the “Company”) (CSE: NARA, FSE:LL3) is pleased to announce that it has entered into a non-binding letter of intent (the “LOI”) with Ayla BioScience, Inc., a company formed under the laws of Delaware, USA (“Ayla BioScience”) to enter into an exclusive distribution agreement and a share purchase agreement. Headquartered in the...Read more
AI-driven precision-oncology analysis identifies patient subtypes with potential enhanced response to glufosfamide Accepted ASCO abstract, submitted in collaboration with Eleison Pharmaceuticals, provides further validation of BullFrog AI’s technology GAITHERSBURG, Md., Nov. 04, 2025 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) ("BullFrog AI" or the "Company"), a technology-enabled drug development...Read more
Results suggest sustained, long-term impact of Omada’s program on weight loss and longer medication persistence SAN FRANCISCO, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual between-visit healthcare provider, announced it will present two posters at ObesityWeek 2025 highlighting the potential impact of Omada’s behavior change program on members currently or previously on GLP-1 medications for weight loss....Read more
KareRx to add plug & play telemedicine pharmacy-support vertical and key manufacturer relationships to Wellgistics' offering Telemedicine remote dispensing market expected to grow from $6.7 billion in 2025 to $13.57 billion by 2032 according to Fortune Business Insights Tampa, Florida--(Newsfile Corp. - November 4, 2025) - Wellgistics Health, Inc. (NASDAQ: WGRX) ("Wellgistics"), a leader in next-generation...Read more
CHICAGO / Nov 03, 2025 / Business Wire / GE HealthCare (Nasdaq: GEHC) is announcing that members of its management team will present at the following upcoming investor conference. Jefferies Global Healthcare Conference in London, England – Tuesday, November 18, 2025 at 9:30 am GMT/4:30 am ET/3:30 am CT A webcast of this event can be accessed at the GE HealthCare website: https://investor.gehealthcare.com/news-events/events on the date...Read more
DALLAS / Nov 03, 2025 / Business Wire / Tenet Healthcare Corporation (NYSE: THC) today announced the pricing of the previously announced private placement offering and has agreed to issue and sell $1.5 billion in aggregate principal amount of senior secured first lien notes due on November 15, 2032, which will bear interest at a rate of 5.500% per annum (the “first lien notes”), and $0.75 billion in aggregate principal amount of senior...Read more
Conference Call and Webcast scheduled for tomorrow, November 4, 2025 at 10:00 am PT SAN JUAN CAPISTRANO, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign(TM) group of companies, which provide post-acute healthcare services and invest in the long-term healthcare industry, primarily in skilled nursing and senior living facilities, announced operating results for the third...Read more
SAN JUAN CAPISTRANO, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign™ group of companies, which invest in and provide skilled nursing and senior living services, physical, occupational and speech therapies, other rehabilitative and healthcare services, and real estate, announced today that it acquired the operations of The Health Center of Eastview, a 90-bed skilled nursing...Read more
SAN JUAN CAPISTRANO, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign™ group of companies, which invest in and provide skilled nursing and senior living services, physical, occupational and speech therapies, other rehabilitative and healthcare services, and real estate, announced today that it acquired the real estate and operations of the following skilled nursing...Read more
Expands in Texas with Acquisition of Personal Care Operations of Del Cielo Home Care Services FRISCO, Texas / Nov 03, 2025 / Business Wire / Addus HomeCare Corporation (NASDAQ: ADUS), a provider of home care services, today announced its financial results for the third quarter and nine months ended September 30, 2025. Third Quarter 2025 Highlights: Net Service Revenues Grow 25.0% to $362.3 Million Net Income of $22.8 Million, or...Read more
Raises Full Year 2025 Adjusted EBITDA Outlook Range FORT LAUDERDALE, Fla. / Nov 03, 2025 / Business Wire / Pediatrix Medical Group, Inc. (NYSE: MD), a leading provider of physician services, today reported earnings of $0.84 per share for the three months ended September 30, 2025. On a non-GAAP basis, Pediatrix reported Adjusted EPS of $0.67. For the 2025 third quarter, Pediatrix reported the following results: Net revenue of $493...Read more
| Company | Change | Last Trade |
|---|---|---|
| PACS Group | 5.12 48.39 | $15.70 |
| Elevance Health | 5.08 1.56 | $330.91 |
| HCA Healthcare | 4.45 0.94 | $477.10 |
| Progyny | 2.27 9.25 | $26.82 |
| Cigna | 1.67 0.62 | $271.33 |
| GeneDx | 1.49 1.16 | $129.55 |
| Univerl Health Services | 1.46 0.65 | $226.50 |
| Centene | 0.70 1.92 | $37.08 |
| CVS Health | 0.60 0.77 | $78.41 |
| Solventum | 0.53 0.70 | $76.19 |
| Pennant | 0.50 2.01 | $25.40 |
| Oscar Health | 0.50 3.60 | $14.38 |
| TruBridge | 0.14 0.69 | $20.51 |
| InnovAge | 0.13 2.69 | $4.97 |
| Aveanna Healthcare | 0.12 1.42 | $8.57 |
Compass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth...
CLICK TO LEARN MORE
Astria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Our lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development...
CLICK TO LEARN MORE